Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

Saved in:
Bibliographic Details
Published inInfectious diseases and therapy Vol. 13; no. 7; pp. 1723 - 1724
Main Authors Wynne, Chris, Balgos, Abundio, Li, Jingxin, Hamilton, Paul, Tirador, Louie, Jaen, Anjuli May, Mo, Chen, Yue, Zijing, Ma, Ying, Wang, Qingshuang, Wen, Rendu, Yao, Zheng, Yu, Jiaping, Yao, Wenrong, Zhang, Jianhui, Zheng, Hui, Hong, Kunxue, Zhu, Fengcai, Liu, Yong
Format Journal Article
LanguageEnglish
Published Cheshire Springer Healthcare 01.07.2024
Springer
Springer Nature B.V
Adis, Springer Healthcare
Subjects
Correction
Infectious Diseases
Internal Medicine
Medicine
Medicine & Public Health
Vaccines
New Zealand
Philippines
China
Online AccessGet full text

Cover

More Information
Bibliography:correction
ObjectType-Correction/Retraction-1
content type line 23
SourceType-Scholarly Journals-1
ISSN:2193-8229
2193-6382
DOI:10.1007/s40121-024-00998-z